TY  - JOUR
TI  - RoB 2: a revised tool for assessing risk of bias in randomised trials
AU  - Jonathan A C Sterne
AU  - Jelena Savović
AU  - Matthew J. Page
AU  - Roy G. Elbers
AU  - Natalie Blencowe
AU  - Isabelle Boutron
AU  - Christopher J Cates
AU  - Hung‐Yuan Cheng
AU  - Mark Corbett
AU  - Sandra Eldridge
AU  - Jonathan Emberson
AU  - Miguel A. Hernán
AU  - Sally Hopewell
AU  - Asbjørn Hróbjartsson
AU  - Daniela R. Junqueira
AU  - Peter Jüni
AU  - Jamie J Kirkham
AU  - Toby J Lasserson
AU  - Tianjing Li
AU  - Alexandra McAleenan
AU  - Barnaby C Reeves
AU  - Sasha Shepperd
AU  - Ian Shrier
AU  - Lesley Stewart
AU  - Kate Tilling
AU  - Ian R. White
AU  - Penny Whiting
AU  - Julian P. T. Higgins
PY  - 2019
JO  - BMJ
DO  - 10.1136/bmj.l4898
UR  - https://doi.org/10.1136/bmj.l4898
AB  - Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
ER  -